RP
Rama Palika
About Rama Palika
Data last updated:
Rama Palika is a Director at Walaz Life Science Private Limited (since 2026), Director at Curesphere Pharmaceuticals Private Limited (since 2025) and Director at Ramasrinivas Constructions Private Limited (since 2022). The companies operate in Pharma and Construction.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Aug 2026 | 2026 | Active | ||
| Director | 08 Jan 2025 | 2025 | Active | ||
| Director | 04 Feb 2022 | 2022 | Active |
Board colleagues of Rama Palika
| Name | DIN | Company | Designation |
|---|---|---|---|
| Palika Srinivas Kumar | 11888778 | Walaz Life Science Private Limited | Director |
| Harshbodhi Prakash Sardar | 10899934 | Curesphere Pharmaceuticals Private Limited | Director |
| Palika Revathi Amrutha Varshini | 09494311 | Ramasrinivas Constructions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rama Palika
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rama Palika
Rama Palika currently holds 3 directorships: Walaz Life Science Private Limited (Director, since 13 Aug 2026); Curesphere Pharmaceuticals Private Limited (Director, since 08 Jan 2025); Ramasrinivas Constructions Private Limited (Director, since 04 Feb 2022).
Rama Palika was first appointed on 04 Feb 2022 as Director at Ramasrinivas Constructions Private Limited. The most recent appointment on record is 13 Aug 2026 at Walaz Life Science Private Limited.
The current boards of Rama Palika's companies include Palika Srinivas Kumar (Walaz Life Science Private Limited), Harshbodhi Prakash Sardar (Curesphere Pharmaceuticals Private Limited), Palika Revathi Amrutha Varshini (Ramasrinivas Constructions Private Limited).